Klinische Studien von Prof. Dr. Noah
logo-noahklinik

CLINICAL STUDIES PROF. DR. NOAH

ZeitraumStudie
2016 – 2017AWB Dermalfiller SF-24, MPG(PI), 39 Patients
2005 – 2006Phase 3 Scar healing, AMG (PI)
2010 – 2012Phase 3 Facelift, MPG (PI)
2010Experimentee lymphatic architectural , AMG (PI)
2011Phase 3 Double Chin Study, MPG (PI)
2012 – 2013Phase 3 Study Simultaneous treatment of upper facelines, AM
2014 – 2015Phase II Treatment of hypertrophic Breast scar, AMG (PI) EudraCT-Nr.: 2012-004355-37 ,7 Patients
2014 – 2020Phase IV Implantation of Orbix medical Breast lifting system, M
2014 – 2015AWB Dermalfiller SF-16, MPG (PI) 8 patients
2015 – 2016Phase 3 double blind Treatment of Clostridium Botulinum ToxiType A of Glabellar lines, AMG (PI) EudraCT-Nr: 2013-002321-34, 20
2015 – 2016Phase 3 Treatment of IncobotulinumtoxinA of upper face lines, AMG (PI) 9 Patients
2015 – 2016Phase 3 open label Treatment with Clostridium Botulinum Toxin Type A of Glabellar lines, AMG (PI) EudraCT-Nr: 2014-003841-86, 23 Patients
2015 – 2017AWB Treatment with Hyaluronic acid in chin and chaw, MPG (PI,) 8 Patie
2016 – 2017Post market follow up Study with Dermalfiller of moderate and severe facial wrinkles/folds, MPG (PI),
8 Patients
2018 – 2019Post market follow up Study with Dermalfiller to to confirm performance and safety of Belotero® Soft Lidocaine and Belotero® Intense Lidocaine in the treatment of nasolabial folds, perioral fine lines and/or for lip volume enhancement, MPG (Sub-I), 25 Patients
2018 – 2019AWB of cell-free autologous Conditioned Serum in patients with skin elasticity loss different grades, MPG (PI) 26 Patients
2019 – 2020Prospective, multicenter, parallel-group, evaluator-blind,
randomized study to investigate the effectiveness and safety of
MRZF111 in the treatment of décolleté wrinkles (MPG)
(PI) 24 Patients
2019 – 2022A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of MT10109L (NivobotulinumtoxinA) for the Treatment of Glabellar Lines With or Without Concurrent Treatment of Lateral Canthal Lines (PI) (AMG) EudraCT-Nr.: 2014-005301-21
(PI) 14 Patients